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Preliminary risk assessment of radiation-induced cardiac sequelae 
in breast cancer patients receiving adjuvant radiotherapy 
after breast conserving therapy
Zbigniew Malinowski, Anna Skowroƒska-Gardas, Zbigniew Jodkiewicz, Eugeniusz Abert
A i m  o f  t h e  s t u d y.  To assess radiation-induced cardiac damage in women with breast cancer irradiated in the course of
breast conserving therapy (BCT), basing on electrocardiogram records.
M a t e r i a l  a n d  m e t h o d s.  Between January 1985 and December 2002, 656 women with breast cancer treated with
BCT received adjuvant radiotherapy at the 1st Department of Radiotherapy of the Maria Sklodowska-Curie Memorial
Cancer Center and Institute of Oncology in Warsaw. All patients had pre-treatment electrocardiogram (ECG). Post-treatment
ECG was performed occasionally, and routinely in those patients who were seen during follow-up between 2001 and 2002. The
study group consisted of 197 patients (103 with tumour of the left breast, 94 with tumour of the right breast) who had at least
one ECG performed after radiotherapy. The follow-up period for assessing radiation-induced cardiac damage ranged from 6
to 186 months, mean: 24 mos.
R e s u l t s.  Analysis of ECG records has shown that non specific and/or ischaemic changes were seen in 60 (58%) of
patients treated for tumours of the left breast and in 22 (21%) patients treated for tumours of the right breast. The incidence
of these changes was threefold higher in patients treated due to tumours of the left breast, as compared to patients with tumours
of the right breast. Those ECG changes had no clinical significance – only in three patients, in whom ECG abnormalities were
also present before treatment, the heart condition required specific medical treatment.
C o n c l u s i o n s.  The results of our study show, that the risk of radiation-induced cardiac damage in breast cancer patients
receiving adjuvant radiotherapy after BCT is significantly higher if the left breast is irradiated. The incidence of cardiac
damage may be significantly reduced by the use of more precise treatment techniques if the left breast has to be irradiated i.e.
radiation beams with strictly limited penumbra. A long follow-up period is required for assessing late radiation-induced
cardiac damage.
Wst´pna ocena ryzyka powik∏aƒ popromiennych 
ze strony mi´Ênia sercowego u chorych na raka piersi 
po oszcz´dzajàcym leczeniu chirurgicznym i radioterapii
C e l.  Celem pracy jest wst´pna ocena powik∏aƒ popromiennych ze strony mi´Ênia sercowego u chorych napromienianych po
oszcz´dzajàcych zabiegach chirurgicznych z powodu raka piersi w oparciu o badania kliniczne i badania EKG.
M a t e r i a ∏  i m e t o d a.  W Zak∏adzie Radioterapii I Centrum Onkologii – Instytutu od 2 stycznia 1985 r. do 30 listopada
2002 r. napromieniano 656 chorych na raka piersi po oszcz´dzajàcym leczeniu chirurgicznym. Wszystkie pacjentki mia∏y
wykonane badanie elektrokardiograficzne przed rozpocz´ciem leczenia. Kontrolne EKG wykonywano okazjonalnie, natomiast
rutynowo u pacjentek kontrolowanych w latach 2001–2002. Badana grupa obejmowa∏a 197 pacjentek, u których wykonano
przynajmniej jedno badanie EKG po radioterapii. Okres obserwacji zmian popromiennych w mi´Êniu sercowym waha∏ si´ od
6 do 186 miesi´cy (Êrednio 24 miesiàce). Guz piersi lewej stwierdzono u 103 pacjentek, prawej u 94.
W y n i k i.  Zestawienie wyników EKG wykaza∏o, ˝e niespecyficzne zmiany zapisu lub zmiany niedokrwienne wystàpi∏y
u 58% chorych leczonych z powodu raka piersi lewej i u 21% chorych na raka piersi prawej. Nale˝y podkreÊliç, ˝e zmiany
niedokrwienne w mi´Êniu sercowym stwierdzano ponad 3-krotnie cz´Êciej po leczeniu nowotworów piersi lewej. Zmiany
mia∏y charakter subkliniczny, tylko w trzech przypadkach, w których zmiany zapisu wyst´powa∏y równie˝ przed leczeniem,
wystàpi∏y zaburzenia wymagajàce leczenia i opieki kardiologicznej.
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Introduction
The number of patients irradiated for breast cancer has,
in the recent years, increased significantly. This pheno-
menon arises from the rising popularity of breast con-
serving therapy (BCT), of which irradiation is a necessary
element. We have also been observing this increase at
the Dept. of Radiotherpy of the Maria Sklodowska-Curie
Memorial Cancer Center and Institute of Oncology in
Poland. Between January 1985 and November 2002 we
had irradiated 656 patients in the course of BCT for
breast cancer.
Radiotherapy applied for breast cancer carries
a number of risks, of which the possibility of developing
myocardial ischaemia is the most serious, leading, in
course, to increased mortality caused by ischaemic heart
disease. The first report concerning a possible increase in
mortality arising from cardiac damage as a late
complication of radiotherapy was published by Haybittle
in 1989 [1]. He reported an increased risk of cardiac
complications in patients irradiated after radical
mastectomy. This finding was later confirmed in the
course of randomized studies and in meta-analyses
performed by Cuzick et al [2]. Conclusions from these
reports advise the use of techniques, which provide
maximal reduction of the dose applied to the heart,
especially in patients with good prognosis and estimated
long survival. Most authors provide data suggesting that
the period of greatest risk of cardiac death begins 7 years
after irradiation, reaches its peak in the second decade
after treatment and then gradually decreases [1, 3, 4]. It
has been shown that irradiation of the left side of the
chest increases the risk of cardiac death by 20%, as
compared to the risk in patients irradiated on the right
side of the chest [5, 6]. In patients in whom the entire
heart volume has been irradiated cardiac mortality
reaches approx. 4.7-6.8% [7]. Naturally, the heart volume
irradiated in the course of BCT is significantly smaller.
Geynes et al. have estimated that in the course of 50%
isodose irradiation from diagonal fields only some 5.7%
of the entire heart volume is irradiated [8], in which case
the risk of cardiac damage remains at the level of 1%
[9]. Most authors report relatively high ratios of heart
damage caused by irradiation for breast cancer. However,
these damages are, in a majority of cases, subclinical.
These signs of damage may be observed in the course of
different investigations [10-13]. At present there is no
detailed data concerning minor cardiac damage, while at
the same time it is very likely that radiotherapy may be
responsible for milder forms of ischaemic heart disease.
In view of the already high and persistently increasing
number of patients with breast cancer, who undergo BCT
we have attempted to evaluate the risk of developing
radiotherapy-induced cardiac damage. Such an analysis is
all the more valuable because patients qualifying for BCT
have good prognosis and are likely to achieve long
survival. This paper presents the results of a pilot study,
which we intend to perform on a much larger scale. It
has been designed in order to perform a generalised,
initial evaluation of the frequency and range of possible
cardiac damage arising from irradiation. It is important to
stress that all our patients presented with initial
electrocardiograms routinely performed before general
anaesthesia. This is one of the reasons why for our
diagnostic tool we have chosen electrocardiography, even
though it has neither the highest sensitivity nor specificity.
The ECG is also the simplest and the most available
method of evaluating possible cardiac damage. Only in
selected cases did we refer our patients for echocardio-
graphy and myocardial perfusion imaging.
Material and methods
Between January 2000 and November 2002 we had performed
control follow-up evaluation of 206 patients irradiated previously
in the course of BCT. The evaluation consisted of case history,
routine physical examination and, in 197 patients (103 irradiated
on the left side of the chest and 94 – on the right) – syste-
matically performed ECG. The length of follow-up from the
end of irradiation varied between 6 and 186 months (mean time
– 24 months) – 45 patients were observed for over 5 years and 10
for over 7 years.
ECG was performed before the onset of therapy and at
different time points after irradiation. The changes observed in
ECG were pronounced as non-specific – abnormalities of
repolarization in the V1-V3 leads (abnormalities of the ST-T
wave with low-voltage or isoelectric T wave). In 44 cases ECG
revealed signs of ischaemia of a variable extent. We used the
chi square test to evaluate the statistical significance of the
obtained results; to calculate the probability of survival free of
ECG abnormalities we used the Kaplan-Meier method, while
the differences observed between patients irradiated on the left
side of the chest and the right side of the chest was calculated
with the log-rank test with the significance level set at 0.05.
Examples of non-specific and ischaemic abnormalities in the
ECG are presented on Figures 1 and 2.
Results
ECG results are presented in Table I.
Only in 3/197 patients did we observe clinically
relevant symptoms of heart damage (with specific signs
observed in the ECG) demanding cardiological treat-
ment. In two cases radiotherapy caused exacerbation of
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ischaemic heart disease also calling for specific treatment.
In these two cases we observed ECG abnormalities prior
to irradiation, although the patients were symptom-free.
One patient, in whom prior to treatment we observed
a significantly slow sinus rhythm, underwent myocardial
infarct 6 months after the termination of radiotherapy.
However, the infarct did not leave any permanent changes
in the ECG and no persistent clinical manifestations.
In 21 cases ECG abnormalities were already present
before the onset of irradiation. Among these patients
irradiation did not cause either exacerbation of ECG
abnormalities nor of clinical symptoms. In the case of all
other patients the ECG abnormalities were subclinical
and no complaints were reported.
Ten patients irradiated on the left side of the chest
received concomitant chemotherapy – four of these were
treated with the AC programme. In two of them we
observed no ECG abnormalities, in one non-specific
changes were observed and in one we observed ischaemic
changes, which were also discernible before the onset of
treatment. The remaining six chemotherapy patients were
treated according to the CMF programme. In four of
them we observed non-specific ECG abnormalities, in
two – extensive signs of ischaemia. Among the patients
irradiated on the right side of the chest only four received
concomitant chemotherapy: three according to the CMF
programme and one according to the AC programme.
No ECG abnormalities were observed in any of them.
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Figure 1A
Figure 1. A. ECG before treatment – normal; B. ECG after treatment – nonspecific abnormalities
Figure 1B
Figure 2A
Figure 2. A. ECG before treatment – normal; B. ECG after – ischaemic changes
Figure 2B
Table I. ECG results of 197 patients irradiated in the course of breast conserving therapy
ECG results Left breast (%) Right breast (%)
No abnormalities after irradiation 38 (36.7%) 56 (60%)
ECG abnormalities observed before irradiation 5 (5%) 16 (19%)
Abnormalities observed after irradiation 60 (58%) 22 (21%)
– non-specific 23 (22%) 11 (12%)
– ischaemic 34 (33%) 10 (9%)
– clinically evident (demanding treatment) 3 (3%) 0
Total 103 94
Post-irradiation ECG abnormalities were observed in
58% of patients treated for cancer of the left breast and
only in 21% of patients treated for cancer of the right
breast.
The difference in the frequency of ECG abnor-
malities after irradiation for cancer of the left breast and
of the right breast reaches high statistical significance
(chi-square 24.10 for p = 0.001). It is also necessary to
stress that abnormalities characteristic of ischaemia were
three times more frequent among patients irradiated for
cancer of the left breast. The probability of survival free of
ECG abnormalities in relation to tumour localization is
presented in Figure 3. The observed differences are
statistically highly significant (p = 0.006).
Discussion
In a pilot study of cardiac damage in women irradiated for
breast cancer ECG abnormalities were found to be more
common among patients irradiated on the left side of the
chest.
These observations are also confirmed by other
authors and in Table II we have compared our results
with those reported from other centers. Most of the cited
reports use dynamic isotope methods of discerning
cardiac damage, thus reporting such changes as subclinical
abnormalities found in visualized perfusion studies and
myocardial ischaemia. However, a precise comparison of
the results reported by different centers is very difficult
due to different techniques of treatment planning and
the variations in treatment fields which they cause. One of
the crucial elements to be considered in treatment
planning is the maximum area of the heart wall (i.e. the
width of the heart as seen on the testing projection picture
from the simulator) which will remain within the
irradiated field. The distance between the most outward
part of the heart outline and the edge of the irradiated
field as seen on the testing projection picture from the
simulator correlates well with the irradiated heart volume
(Figure 4). Hurkmans et al. used this very parameter to
calculate the risk of heart damage acc. to their own
developed model [4, 9]. If this distance is less than 1.5 cm
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Table II. A comparison of the ratio of post-irradiation ECG abnormalities observed in the course of breast conserving therapy (BCT) at the 1st
Department of Radiatherapy of the Maria Sklodowska-Curie Memorial Cancer Centre with similar results reported by other centers
Center Treatment modality Ratio of observed ECG abnormalities
left breast right breast
Radiumhemmet RT 25% 0%
Stockholm; 1994 data [11]
Radiumhemmet RT 50% -
Stockholm; 1996 data [9]
Dept. of Radiation Oncology; RT + CHTH 60% -
Durham NC, USA [10] RT 50% -
Dept. of Radiology, Royal Marsden Hospital, RT 71% 17%
London [12]
1st Dept. of Radiotherapy, RT 58% 21%
Institute of Oncology, Warsaw, Poland
RT – radiotherapy
CHTH – chemotherapy
Figure 3. Probability of survival free of ECG abnormalities after
irradiation of the left (group 1) and the right (group 2) side of the
chest
Figure 4. Schematic picture of the heart and lung volumes within the
irradiated field – side projection
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– the risk of cardiac damage remains below 1%. Their
calculations were performed for a dose of 50 Gy given
in 25 fractions with no concomitant systemic chemo-
therapy. Other authors maintain, that the aforementioned
distance should not exceed 1 cm, however it is not always
technically possible to altogether avoid applying radiation
to the heart. The standard procedure is to use two oblique
fields, in case of which the entire elimination of the heart
from the irradiated area is difficult (Figure 5). The
presence of a part of the heart volume within the
irradiated area is confirmed on the CT scan of the lower
part of the field (Figure 6). Fuller et al. stress that even
providing modern techniques and careful treatment
planning the left descending artery and the area of its
supply (the anterior wall of the heart) may receive
a relatively high radiation dose [14]. Gogliardi and Magee
have shown that due to anatomical variations of the
heart’s position in approximately 9% of cases it is
impossible to avoid its irradiation [15, 16].
Precise treatment planning is of extreme importance.
It should include corrections arising from the testing
projection pictures taken on the simulator, from isodose
graphs and from CT scans. An example of such correc-
tions is presented on Figure 7. According to the first
version of the myocardium would receive a significant
radiation dose. After corrections the isodose crossing the
myocardium has only a 10% dose value. In the course of
our studies we have found that in 34% of cases it is
possible to completely eliminate the heart from the
irradiated field providing that the initial heart volume at
risk of irradiation is estimated from the simulator scans.
Irradiation with the acceptable dose was possible in 40%
of cases, while in the remaining 26% of cases it was
impossible to reduce the size of the irradiated part of the
heart below 2-3 cm.
Conclusions
The initial results prove that the risk of post-radiotherapy
heart damage is increased after irradiation of the left
breast.
The number of cardiac complications may be
significantly reduced by decreasing the dose applied to the
heart which is possible with precise treatment planning
Figure 5. Diagram showing a cross section obtained during computer
treatment planning – the heart volume found within the irradiated
field discernible in the lower part of the field
Figure 6. CT scan of the lower part of the irradiated field
Figure 7A
Figure 7. A. Treatment planning – myocardium within range of the beam; B. Same patient – treatment planning after corrections – myocardium only
within range of the 10% isodose
Figure 7B
the lung
the heart
isocenter
lateral field
medial field
and the use of radiation beams with strictly limited
penumbra.
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